2-Amino-5-phosphonovalerate
Quisqualic Acid
N-Methylaspartate
Receptors, Neurotransmitter
Cell surface receptors that bind signalling molecules released by neurons and convert these signals into intracellular changes influencing the behavior of cells. Neurotransmitter is used here in its most general sense, including not only messengers that act to regulate ion channels, but also those which act on second messenger systems and those which may act at a distance from their release sites. Included are receptors for neuromodulators, neuroregulators, neuromediators, and neurohumors, whether or not located at synapses.
Receptors, N-Methyl-D-Aspartate
A class of ionotropic glutamate receptors characterized by affinity for N-methyl-D-aspartate. NMDA receptors have an allosteric binding site for glycine which must be occupied for the channel to open efficiently and a site within the channel itself to which magnesium ions bind in a voltage-dependent manner. The positive voltage dependence of channel conductance and the high permeability of the conducting channel to calcium ions (as well as to monovalent cations) are important in excitotoxicity and neuronal plasticity.
Receptors, Amino Acid
Cell surface proteins that bind amino acids and trigger changes which influence the behavior of cells. Glutamate receptors are the most common receptors for fast excitatory synaptic transmission in the vertebrate central nervous system, and GAMMA-AMINOBUTYRIC ACID and glycine receptors are the most common receptors for fast inhibition.
6-Cyano-7-nitroquinoxaline-2,3-dione
Amino Acids
Excitatory Amino Acid Antagonists
Valine
Aspartic Acid
Kainic Acid
(2S-(2 alpha,3 beta,4 beta))-2-Carboxy-4-(1-methylethenyl)-3-pyrrolidineacetic acid. Ascaricide obtained from the red alga Digenea simplex. It is a potent excitatory amino acid agonist at some types of excitatory amino acid receptors and has been used to discriminate among receptor types. Like many excitatory amino acid agonists it can cause neurotoxicity and has been used experimentally for that purpose.
Glutamic Acid
Glutamates
Receptors, Glutamate
Cell-surface proteins that bind glutamate and trigger changes which influence the behavior of cells. Glutamate receptors include ionotropic receptors (AMPA, kainate, and N-methyl-D-aspartate receptors), which directly control ion channels, and metabotropic receptors which act through second messenger systems. Glutamate receptors are the most common mediators of fast excitatory synaptic transmission in the central nervous system. They have also been implicated in the mechanisms of memory and of many diseases.
Synapses
Specialized junctions at which a neuron communicates with a target cell. At classical synapses, a neuron's presynaptic terminal releases a chemical transmitter stored in synaptic vesicles which diffuses across a narrow synaptic cleft and activates receptors on the postsynaptic membrane of the target cell. The target may be a dendrite, cell body, or axon of another neuron, or a specialized region of a muscle or secretory cell. Neurons may also communicate via direct electrical coupling with ELECTRICAL SYNAPSES. Several other non-synaptic chemical or electric signal transmitting processes occur via extracellular mediated interactions.
Hippocampus
A curved elevation of GRAY MATTER extending the entire length of the floor of the TEMPORAL HORN of the LATERAL VENTRICLE (see also TEMPORAL LOBE). The hippocampus proper, subiculum, and DENTATE GYRUS constitute the hippocampal formation. Sometimes authors include the ENTORHINAL CORTEX in the hippocampal formation.
Spinal Cord
Evoked Potentials
Electrical responses recorded from nerve, muscle, SENSORY RECEPTOR, or area of the CENTRAL NERVOUS SYSTEM following stimulation. They range from less than a microvolt to several microvolts. The evoked potential can be auditory (EVOKED POTENTIALS, AUDITORY), somatosensory (EVOKED POTENTIALS, SOMATOSENSORY), visual (EVOKED POTENTIALS, VISUAL), or motor (EVOKED POTENTIALS, MOTOR), or other modalities that have been reported.
Sequence Homology, Amino Acid
Synaptic Transmission
The communication from a NEURON to a target (neuron, muscle, or secretory cell) across a SYNAPSE. In chemical synaptic transmission, the presynaptic neuron releases a NEUROTRANSMITTER that diffuses across the synaptic cleft and binds to specific synaptic receptors, activating them. The activated receptors modulate specific ion channels and/or second-messenger systems in the postsynaptic cell. In electrical synaptic transmission, electrical signals are communicated as an ionic current flow across ELECTRICAL SYNAPSES.
Action Potentials
Neurons
Rats, Inbred Strains
Amino Acid Substitution
The naturally occurring or experimentally induced replacement of one or more AMINO ACIDS in a protein with another. If a functionally equivalent amino acid is substituted, the protein may retain wild-type activity. Substitution may also diminish, enhance, or eliminate protein function. Experimentally induced substitution is often used to study enzyme activities and binding site properties.
Cloning, Molecular
Amino Acids, Essential
Amino Acid Transport Systems
Amino Acid Motifs
Sequence Alignment
The arrangement of two or more amino acid or base sequences from an organism or organisms in such a way as to align areas of the sequences sharing common properties. The degree of relatedness or homology between the sequences is predicted computationally or statistically based on weights assigned to the elements aligned between the sequences. This in turn can serve as a potential indicator of the genetic relatedness between the organisms.
Base Sequence
Escherichia coli
A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc.
Mutation
Binding Sites
Molecular Sequence Data
Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories.
Mutagenesis, Site-Directed
DNA, Complementary
Sequence Homology, Nucleic Acid
Peptide Fragments
Protein Conformation
The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain).
Models, Molecular
Structure-Activity Relationship
Protein Structure, Tertiary
The level of protein structure in which combinations of secondary protein structures (alpha helices, beta sheets, loop regions, and motifs) pack together to form folded shapes called domains. Disulfide bridges between cysteines in two different parts of the polypeptide chain along with other interactions between the chains play a role in the formation and stabilization of tertiary structure. Small proteins usually consist of only one domain but larger proteins may contain a number of domains connected by segments of polypeptide chain which lack regular secondary structure.
Substrate Specificity
Protein Binding
DNA
A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine).
Peptides
Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are linear polypeptides that are normally synthesized on RIBOSOMES.
Plasticity of first-order sensory synapses: interactions between homosynaptic long-term potentiation and heterosynaptically evoked dopaminergic potentiation. (1/986)
Persistent potentiations of the chemical and electrotonic components of the eighth nerve (NVIII) EPSP recorded in vivo in the goldfish reticulospinal neuron, the Mauthner cell, can be evoked by afferent tetanization or local dendritic application of an endogenous transmitter, dopamine (3-hydroxytyramine). These modifications are attributable to the activation of distinct intracellular kinase cascades. Although dopamine-evoked potentiation (DEP) is mediated by the cAMP-dependent protein kinase (PKA), tetanization most likely activates a Ca2+-dependent protein kinase via an increased intracellular Ca2+ concentration. We present evidence that the eighth nerve tetanus that induces LTP does not act by triggering dopamine release, because it is evoked in the presence of a broad spectrum of dopamine antagonists. To test for interactions between these pathways, we applied the potentiating paradigms sequentially. When dopamine was applied first, tetanization produced additional potentiation of the mixed synaptic response, but when the sequence was reversed, DEP was occluded, indicating that the synapses potentiated by the two procedures belong to the same or overlapping populations. Experiments were conducted to determine interactions between the underlying regulatory mechanisms and the level of their convergence. Inhibiting PKA does not impede tetanus-induced LTP, and chelating postsynaptic Ca2+ with BAPTA does not block DEP, indicating that the initial steps of the induction processes are independent. Pharmacological and voltage-clamp analyses indicate that the two pathways converge on functional AMPA/kainate receptors for the chemically mediated EPSP and gap junctions for the electrotonic component or at intermediaries common to both pathways. A cellular model incorporating these interactions is proposed on the basis of differential modulation of synaptic responses via receptor-protein phosphorylation. (+info)Low resting potential and postnatal upregulation of NMDA receptors may cause Cajal-Retzius cell death. (2/986)
Using in situ patch-clamp techniques in rat telencephalic slices, we have followed resting potential (RP) properties and the functional expression of NMDA receptors in neocortical Cajal-Retzius (CR) cells from embryonic day 18 to postnatal day 13, the time around which these cells normally disappear. We find that throughout their lives CR cells have a relatively depolarized RP (approximately -50 mV), which can be made more hyperpolarized (approximately -70 mV) by stimulation of the Na/K pump with intracellular ATP. The NMDA receptors of CR cells are subjected to intense postnatal upregulation, but their similar properties (EC50, Hill number, sensitivity to antagonists, conductance, and kinetics) throughout development suggest that their subunit composition remains relatively homogeneous. The low RP of CR cells is within a range that allows for the relief of NMDA channels from Mg2+ blockade. Our findings are consistent with the hypothesis that CR cells may degenerate and die subsequent to uncontrolled overload of intracellular Ca2+ via NMDA receptor activation by ambient glutamate. In support of this hypothesis we have obtained evidence showing the protection of CR cells via in vivo blockade of NMDA receptors with dizocilpine. (+info)Activity-dependent metaplasticity of inhibitory and excitatory synaptic transmission in the lamprey spinal cord locomotor network. (3/986)
Paired intracellular recordings have been used to examine the activity-dependent plasticity and neuromodulator-induced metaplasticity of synaptic inputs from identified inhibitory and excitatory interneurons in the lamprey spinal cord. Trains of spikes at 5-20 Hz were used to mimic the frequency of spiking that occurs in network interneurons during NMDA or brainstem-evoked locomotor activity. Inputs from inhibitory and excitatory interneurons exhibited similar activity-dependent changes, with synaptic depression developing during the spike train. The level of depression reached was greater with lower stimulation frequencies. Significant activity-dependent depression of inputs from excitatory interneurons and inhibitory crossed caudal interneurons, which are central elements in the patterning of network activity, usually developed between the fifth and tenth spikes in the train. Because these interneurons typically fire bursts of up to five spikes during locomotor activity, this activity-dependent plasticity will presumably not contribute to the patterning of network activity. However, in the presence of the neuromodulators substance P and 5-HT, significant activity-dependent metaplasticity of these inputs developed over the first five spikes in the train. Substance P induced significant activity-dependent depression of inhibitory but potentiation of excitatory interneuron inputs, whereas 5-HT induced significant activity-dependent potentiation of both inhibitory and excitatory interneuron inputs. Because these metaplastic effects are consistent with the substance P and 5-HT-induced modulation of the network output, activity-dependent metaplasticity could be a potential mechanism underlying the coordination and modulation of rhythmic network activity. (+info)Impairment of neocortical long-term potentiation in mice deficient of endothelial nitric oxide synthase. (4/986)
The role of the possible retrograde messenger nitric oxide (NO) in the induction of long-term potentiation (LTP) was studied in supragranular layers of somatosensory cortical slices obtained from adult mice. High-frequency stimulation produced a slowly rising, long-lasting (50 min) and significant (P < 0.001) increase in the extracellular synaptic response by 23%. The induction of LTP was independent from activation of N-methyl-D-aspartate (NMDA) receptors, but prevented by bath application of NG-nitro-L-arginine methyl ester (L-NAME), indicating that one or several of the different NO synthases (NOS) produced NO within the postsynaptic neuron. No LTP could be induced in knockout mice lacking the endothelial NOS (eNOS) isoform. These data suggest that eNOS is involved in an NMDA receptor-independent form of LTP in the rodent cerebral cortex. (+info)NMDA-dependent currents in granule cells of the dentate gyrus contribute to induction but not permanence of kindling. (5/986)
Single-electrode voltage-clamp techniques and bath application of the N-methyl-D-aspartate (NMDA) receptor antagonist 2-amino-5-phosphonovaleric acid (APV) were used to study the time course of seizure-induced alterations in NMDA-dependent synaptic currents in granule cells of the dentate gyrus in hippocampal slices from kindled and normal rats. In agreement with previous studies, granule cells from kindled rats examined within 1 wk after the last of 3 or 30-35 generalized tonic-clonic (class V) seizures demonstrated an increase in the NMDA receptor-dependent component of the perforant path-evoked synaptic current. Within 1 wk of the last kindled seizure, NMDA-dependent charge transfer underlying the perforant path-evoked current was increased by 63-111% at a holding potential of -30 mV. In contrast, the NMDA-dependent component of the perforant-evoked current in granule cells examined at 2.5-3 mo after the last of 3 or 90-120 class V seizures did not differ from age-matched controls. Because the seizure-induced increases in NMDA-dependent synaptic currents declined toward control values during a time course of 2.5-3 mo, increases in NMDA-dependent synaptic transmission cannot account for the permanent susceptibility to evoked and spontaneous seizures induced by kindling. The increase in NMDA receptor-dependent transmission was associated with the induction of kindling but was not responsible for the maintenance of the kindled state. The time course of alterations in NMDA-dependent synaptic current and the dependence of the progression of kindling and kindling-induced mossy fiber sprouting on repeated NMDA receptor activation are consistent with the possibility that the NMDA receptor is part of a transmembrane signaling pathway that induces long-term cellular alterations and circuit remodeling in response to repeated seizures, but is not required for permanent seizure susceptibility in circuitry altered by kindling. (+info)17beta-estradiol enhances NMDA receptor-mediated EPSPs and long-term potentiation. (6/986)
Gonadal steroid hormones influence CNS functioning through a variety of different mechanisms. To test the hypothesis that estrogen modulates synaptic plasticity in the hippocampus, in vitro hippocampal slices from 2-mo-old Sprague-Dawley male rats were used to determine the effect of 17beta-estradiol on both N-methyl-D-aspartate (NMDA) receptor-mediated excitatory postsynaptic potentials (EPSPs) through intracellular recordings and long-term potentiation (LTP) through extracellular recordings. Intracellular EPSPs and extracellular field EPSPs (fEPSPs) were recorded from CA1 pyramidal cells by stimulating Schaffer collateral fibers. In intracellular experiments, slices were perfused with medium containing bicuculline (5 microM) and low Mg2+ (0.1 mM) to enhance the NMDA receptor-mediated currents and 6, 7-dinitroquinoxaline-2,3-dione (DNQX) (10 microM) to block the alpha-amino-3-hydroxy-5-methyl-4-isoxazoleproprianate (AMPA) receptor-mediated component. The effects of 17beta-estradiol on NMDA receptor-mediated activity were excitatory; concentrations >10 nM induced seizure activity, and lower concentrations (1 nM) markedly increased the amplitude of NMDA-mediated EPSPs (both the first and second responses increased during paired pulse stimulation by 180 and 197%, respectively). In extracellular experiments, slices perfused with 17beta-estradiol (100 pM) exhibited a pronounced, persisting, and significant enhancement of LTP of both the fEPSP slope (192%) and fEPSP amplitude (177%) compared with control slices (fEPSP slope = 155%; fEPSP amplitude = 156%) 30 min after high-frequency stimulation. These data demonstrate that estrogen enhances NMDA receptor-mediated currents and promotes an enhancement of LTP magnitude. (+info)Retinal input induces three firing patterns in neurons of the superficial superior colliculus of neonatal rats. (7/986)
By using an in vitro isolated brain stem preparation, we recorded extracellular responses to electrical stimulation of the optic tract (OT) from 71 neurons in the superficial superior colliculus (SC) of neonatal rats (P1-13). At postnatal day 1 (P1), all tested neurons (n = 10) already received excitatory input from the retina. Sixty-nine (97%) superficial SC neurons of neonatal rats showed three response patterns to OT stimulation, which depended on stimulus intensity. A weak stimulus evoked only one spike that was caused by activation of non-N-methyl-D-aspartate (NMDA) glutamate receptors. A moderate stimulus elicited a short train (<250 ms) of spikes, which was induced by activation of both NMDA and non-NMDA receptors. A strong stimulus gave rise to a long train (>300 ms) of spikes, which was associated with additional activation of L-type high-threshold calcium channels. The long train firing pattern could also be induced either by temporal summation of retinal inputs or by blocking gamma-aminobutyric acid-A receptors. Because retinal ganglion cells show synchronous bursting activity before eye opening at P14, the retinotectal inputs appear to be sufficient to activate L-type calcium channels in the absence of pattern vision. Therefore activation of L-type calcium channels is likely to be an important source for calcium influx into SC neurons in neonatal rats. (+info)NMDA receptor characterization and subunit expression in rat cultured mesencephalic neurones. (8/986)
1. NMDA-induced changes in free intracellular Ca2+ concentration ([Ca2+]i) were determined in individual cultured rat mesencephalic neurones by the fura-2 method. mRNA expression encoding NMDA receptor subunits (NR1, NR2A-D) was examined by RT-PCR. 2. NMDA (1-100 microM, plus 10 microM glycine) induced a concentration-dependent increase in [Ca2+]i (EC50 = 5.7 microM). The effect of NMDA was virtually insensitive to tetrodotoxin (0.3 microM) and nitrendipine (1 microM), but dependent on extracellular Ca2+. 5,7-Dichlorokynurenic acid (10 microM), a specific antagonist at the glycine binding site on the NMDA receptor, abolished the NMDA response. 3. Memantine, an open-channel blocker, and ifenprodil, a preferential non-competitive NR1/NR2B receptor antagonist diminished the NMDA effect with an IC50 value of 0.17 and 1 microM, respectively. Ethanol at 50 and 100 mM caused about 25 and 45%-inhibition, respectively. 4. Agarose gel analysis of the PCR products followed by ethidium bromide fluorescence or CSPD chemiluminescence detection revealed an almost exclusive expression of the NR1 splice variants lacking exon (E) 5 and E22. The 3' splice form without both E21 and E22 exceeded that containing E21 by approximately 4 fold. The relative amounts of NR2A, NR2B, NR2C corresponded to approximately 1:2:1. NR2D mRNA was also detectable. 5. In conclusion, mesencephalic neurones bear ethanol-sensitive NMDA receptors which might be involved in the development of ethanol dependence and withdrawal. The high affinity of NMDA to this receptor, its sensitivity to ifenprodil and memantine may suggest that the mesencephalic NMDA receptor comprises the NR1 splice variant lacking E5, NR2B, and NR2C, respectively. (+info)
Heptanoic acid,2-amino-7-phosphono-, (2R)- supplier | CasNO.81338-23-0
Pharmacological effects of the non‐competitive NMDA antagonist CNS 1102 in normal volunteers - Enlighten: Publications
2R)-2-Amino-5-phosphonopentanoic acid | C5H12NO5P - PubChem
Accela Chembio Inc 3-AMINO-4-PYRIDAZINECARB 0.25G 3-AMINO-4-PYRIDAZINECARB
| Fisher Scientific
Characterization of the cerebroprotective efficacy of the competitive NMDA receptor antagonist CGP40116 in a rat model of focal...
CAS # 90600-20-7, (S)-N-Boc-allylglycine, (S)-N-tert-Butoxycarbonyl-2-amino-4-pentenoic acid
ChemIDplus - 1575-72-0 - UMYDNZXEHYSVFY-UHFFFAOYSA-N - 2-Propyl-4-pentenoic acid - Similar structures search, synonyms,...
Professor David Jane - MRC Centre for Synaptic Plasticity publications
4-AMINO-2,6-DICHLOROPYRIMIDINE 10132-07-7, China 4-AMINO-2,6-DICHLOROPYRIMIDINE 10132-07-7 Manufacturers, China 4-AMINO-2,6...
446-08-2, 2-Amino-5-fluorobenzoic acid, CAS No 446-08-2 2-Amino-5-fluorobenzoic acid tr
s-3-amino-2-tert-butoxycarbonylamino-propionic-acid | VWR
fmoc-r-3-amino-4-4-bromophenyl-butyric-acid | VWR
Plus it
D-AP5 (mM/ml), NMDA glutamate site antagonist (CAS 79055-68-8) (ab144482)
E)-2-Pentenoic acid, 2-propyl, trimethylsilyl ester
CNQX and D-AP5 stability
3-Amino-2-oxy-propoxy-substituted isothiazoles - Patent # 4119718 - PatentGenius
CAS # 80430-22-4, Methyl 5-amino-2-methansulfonyloxybenzoate, Methyl 3-amino-6-methansulfonyloxybenzoate
PQR | 3-[[(2r,3s,4r,5r)-5-(6-amino-8-bromo-purine-1,3,7-triium-9-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methylcarbamoyl]-3...
PQR | (2s)-5-amino-2-[3-(4-aminobutylamino)propylamino]-5-oxo-pentanoic acid
鬘夫人葡萄糖胺+海藻鈣
NMDA Receptor Antagonist / Antiarrhythmic Combinations - Prices and Information - GoodRx
TCN 201 | NMDA receptor antagonist | Hello Bio
Category:NMDA receptor antagonists | Psychology Wiki | FANDOM powered by Wikia
L-2-amino-3,3-dimethylbutanoic acid CAS 20859-02-3,L-2-amino-3,3-dimethylbutanoic acid suppliers L-2-amino-3,3-dimethylbutanoic...
Alfa Aesar™ 2-Amino-4-methylbenzothiazole, 98% 5g Alfa Aesar™ 2-Amino-4-methylbenzothiazole, 98%
3-Amino-4-methoxybenzenesulphonic acid | VWR
Neuroprotective efficiency of NMDA receptor blockade in the striatum and CA3 hippocampus after various durations of cerebral...
Excitatory amino acid antagonists for acute stroke - SINAPSE
Characterization and Toxicity of Amanita cokeri Extract | SpringerLink
3-Amino-4-pyrazolecarboxylic acid - Alfa Chemistry
5-Amino-2-chlorobenzenesulfonamide - Alfa Chemistry
1R,2S)-Methyl 1-amino-2-vinylcyclopropanecarboxy - (1R,2S)-Methyl 1-amino-2-vinylcyclopropanecarboxy Exporter, Manufacturer,...
2016 2,2-bis(3-amino-4-hydroxyphenyl)-hexafluoropropane (CAS 83558-87-6) Global Market Report : ReportsnReports
4-Amino-7-chloroquinazoline/19808-36-7-ChonTech
d-Methadone Is Antinociceptive in the Rat Formalin Test | Journal of Pharmacology and Experimental Therapeutics
Blockade of NR2A-Containing NMDA Receptors Induces Tau Phosphorylation in Rat Hippocampal Slices
Differential effects of peripheral NMDA and non-NMDA receptors on response of persistent nociception induced by subcutaneous...
Plus it
Expressions of N-methyl-D-aspartate receptors NR2A and NR2B su...
ZD 9379 | NMDA antagonist | ZD9379 | CAS [170142-20-8] | Axon 2261 | Axon Ligand™ with |100% purity available from stock from...
NMDA receptor antagonists - Research & Scientific News - ClusterBusters
China 3-Amino-5-Fluorobenzotrifluoride CAS:454-67-1 manufacturer supplier producer and factory-NINGBO INNO PHARMCHEM CO.,LTD.
2-Amino-3,5-Dibromophenyl)Methanol supplier distributor- CAS 50739-76-9
Fosforibozilaminoimidazolna karboksilaza - Википедија
Age dependence of homosynaptic non-NMDA mediated long-term depression in field CA1 of rat hippocampal slices<...
NMDA receptor blockade prevents the increase in protein kinase C substrate (protein F1) phosphorylation produced by long-term...
Distribution of NADPH-diaphorase and expression of nNOS, N-Methyl-D-Aspartate receptor (NMDAR1) and Non-NMDA glutamate receptor...
Plus it
Selfotel - Wikipedia
Olneys lesions
Alfa Aesar™ 2-Amino-3-fluorobenzeneboronic acid pinacol ester, 96% 1g Alfa Aesar™ 2-Amino-3-fluorobenzeneboronic acid pinacol...
2-AMINO-6-METHYL PYRIDINE
TRC | Details of CAS = , ChemicalName = (2R,5S)-L-Menthol-5-(4-amino-2-oxo-1(2H)-pyrimidinyl-13C)-1,3-oxathiolane-2-carboxylate...
2-amino-6-fluoro-3-methylbenzoic acid | 874804-26-9
H-Abu-NH2 - Creative Peptides
Index of biochemistry articles
... amino - amino acid - amino acid receptor - amino acid sequence - amino acid sequence homology - aminobutyric acid - ammonia - ... essential amino acid - ester - estradiol receptor - estrogen receptor - ethanol - ether - eukaryote - evolution - evolutionary ... Articles related to biochemistry include: Contents: Top 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 2-amino-5- ... phosphonovalerate - 3' end - 5' end ABC-Transporter Genes - abl gene - acetic acid - acetyl CoA - acetylcholine - ...
List of MeSH codes (D12.125)
... amino acids, aromatic MeSH D12.125.072.050.342 - dextrothyroxine MeSH D12.125.072.050.685 - phenylalanine MeSH D12.125.072.050. ... 2-aminoadipic acid MeSH D12.125.119.170 - aspartic acid MeSH D12.125.119.170.150 - d-aspartic acid MeSH D12.125.119.170.275 - ... 5-hydroxytryptophan MeSH D12.125.072.050.875 - tyrosine MeSH D12.125.072.050.875.064 - betalains MeSH D12.125.072.050.875.064. ... 2-amino-5-phosphonovalerate MeSH D12.125.740.675 - phosphocreatine MeSH D12.125.740.700 - phosphoserine MeSH D12.125.740.725 - ...
AP5
... (also known as APV, (2R)-amino-5-phosphonovaleric acid, or (2R)-amino-5-phosphonopentanoate) is a chemical compound used as ... Disruption by the NMDA Receptor Antagonist DL-2-Amino-5-Phosphonovalerate Gustafsson B., Wigström H., Abraham W.C., and Huang Y ...
Dopamine, but not glutamate, receptor blockade in the basolateral amygdala attenuates conditioned reward in a rat model of...
... a kainate/alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonist (CNQX, 0.83 microgram/side), or ... In contrast, infusion of a DA D1 receptor antagonist (SCH-23390, 2 micrograms/side) or a combination of SCH-23390 and a DA D2/ ... Methods: Rats were allowed 2 weeks of 3-h daily sessions of cocaine self-administration along a fixed ratio (FR) 1 schedule. ... Results: Infusion of an NMDA receptor antagonist (AP-5, 1.97 micrograms/side), ...
Entorhinal cortex directs learning-related changes in CA1 representations | Nature
2. For instance, the learning of a reward site by rodents requires the development of an over-representation of that location ... d-aspartate receptors to α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors23, and previous in vitro and in vivo ... 5: EC3 activity adapts to the environment.. a, In contrast to environment A (top), environment B (bottom) involves a blank belt ... 2: BTSP underlies experience-dependent shaping of CA1 representations.. a, Schematics showing features of BTSP. BTSPs ...
Ethanol Enhances Neurosteroidogenesis in Hippocampal Pyramidal Neurons by Paradoxical NMDA Receptor Activation | Journal of...
2A) and 1 μm dutasteride (EPSP change: 154.0 ± 8.1% of baseline, n = 5) (Fig. 2A). Exploiting an earlier observation that ... Figure 2. Ethanol-mediated LTP inhibition involves activation of NMDARs and 5α-reductase. A, In control slices, LTP is readily ... 2B). Administration of APV alone 30 min before HFS followed by washout had no effect on LTP induction (EPSP change: 157.7 ± 9.2 ... The staining was enhanced when incubated with 1 μm NMDA for 5 min but was inhibited by pretreatment with 1 μm finasteride or ...
PRIME PubMed | Effects of competitive NMDA receptor antagonists on excitatory amino acid-evoked currents in mouse spinal cord...
Effects of competitive NMDA receptor antagonists on excitatory amino acid-evoked currents in mouse spinal cord neurones. ... DrugExcitatory Amino Acid AgonistsExcitatory Amino Acid AntagonistsExcitatory Amino AcidsGlutamic AcidKainic AcidMembrane ... Excitatory amino acid receptor mediation of sensory inputs to functionally identified dorsal horn neurons in cat spinal cord. ... Effects of competitive NMDA receptor antagonists on excitatory amino acid-evoked currents in mouse spinal cord neurones.. ...
DeCS
Amino-2 phosphono-5 valérate Entry term(s):. 2 Amino 5 phosphonopentanoate. 2 Amino 5 phosphonopentanoic Acid. 2 Amino 5 ... phosphonovalerate. 2 Amino 5 phosphonovaleric Acid. 2-APV. 2-Amino-5-phosphonopentanoate. 2-Amino-5-phosphonopentanoic Acid. 2- ... excitatory amino acid receptors.. Allowable Qualifiers:. AA analogs & derivatives. AD administration & dosage. AE adverse ... 2-Amino-5-phosphonovalerate - Preferred Concept UI. M0024150. Scope note. The D-enantiomer is a potent and specific antagonist ...
Activity-dependent expression of inositol 1,4,5-trisphosphate receptor type 1 in hippocampal neurons - Fingerprint -...
Physiology Pharmacology - Research output
- Tel Aviv University
Nadler, E., Gillo, B., Lass, Y. & Oron, Y., 21 Apr 1986, In: FEBS Letters. 199, 2, p. 208-212 5 p.. Research output: ... Frenk, H., Liban, A., Urca, G. & Teichberg, V. I., 14 May 1986, In: Brain Research. 373, 1-2, p. 222-226 5 p.. Research output ... Dascal, N., Yekuel, R. & Oron, Y., Apr 1984, In: Journal of Experimental Zoology. 230, 1, p. 131-135 5 p.. Research output: ... Shemesh, T. & Kozlov, M. M., Mar 2007, In: Biophysical Journal. 92, 5, p. 1512-1521 10 p.. Research output: Contribution to ...
DeCS 2013 - December 17, 2013 version
2-Amino-5-phosphonovaleric Acid use 2-Amino-5-phosphonovalerate 2-Amino-6-(1,2,3-trihydroxypropyl)-4(3H)-pteridinone use ... 2-Dehydro-3-Deoxyphosphoheptonate Aldolase use 3-Deoxy-7-Phosphoheptulonate Synthase 2-Fluoro-2-deoxy-D-glucose use ... 2,6-Dichlorophenolindophenol use 2,6-Dichloroindophenol 3 beta-Hydroxy-delta-5-Steroid Dehydrogenase use Progesterone Reductase ... 2-Oxoisovalerate Dehydrogenase (Lipoamide) use 3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide) 2-PAM Compounds use ...
Журнал высшей нервной деятельности им. И.П. Павлова. T. 72, Номер
3, 2022
Butcher S.P., Davis S., Morris R.G. A dose-related impairment of spatial learning by the NMDA receptor antagonist, 2-amino-5- ... phosphonovalerate (AP5). Eur. Neuropsychopharmacol. 1990. 1(1): 15-20. https://doi.org/10.1016/0924-977x(90)90005-u ... https://doi.org/10.1002/(SICI)1098-1063(1997)7:1 ,95::AID-HIPO10,3.0.CO;2-D ...
Jian-Min Shi - NeL.edu
Excitatory Amino Acid Antagonists:pharmacology, Hypothalamus:drug effects, Injections, Intraventricular, Male, Prolactin: ... Journal Article 2018; 39(2): 143-147 PubMed PMID: 30183208 Citation OBJECTIVE: To observe the clinical curative effects of ... Journal Article 2007; 28(5): 580-584 PubMed PMID: 17984952 Keywords: Adult, China, Chromosome Aberrations, Chromosomes, Human, ... Journal Article 2003; 24(6): 435-439 PubMed PMID: 15073571 Keywords: 2-Amino-5-phosphonovalerate:pharmacology, Age Factors, ...
DeCS 2014 - December 16, 2014 version
2-Amino-5-phosphonovaleric Acid use 2-Amino-5-phosphonovalerate 2-Amino-6-(1,2,3-trihydroxypropyl)-4(3H)-pteridinone use ... 2-Dehydro-3-Deoxyphosphoheptonate Aldolase use 3-Deoxy-7-Phosphoheptulonate Synthase 2-Fluoro-2-deoxy-D-glucose use ... 2,6-Dichlorophenolindophenol use 2,6-Dichloroindophenol 3 beta-Hydroxy-delta-5-Steroid Dehydrogenase use Progesterone Reductase ... 2-Oxoisovalerate Dehydrogenase (Lipoamide) use 3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide) 2-PAM Compounds use ...
DeCS 2011 - December 22, 2011 version
2-Amino-5-phosphonovaleric Acid use 2-Amino-5-phosphonovalerate 2-Amino-6-(1,2,3-trihydroxypropyl)-4(3H)-pteridinone use ... 2-Dehydro-3-Deoxyphosphoheptonate Aldolase use 3-Deoxy-7-Phosphoheptulonate Synthase 2-Fluoro-2-deoxy-D-glucose use ... 2,6-Dichlorophenolindophenol use 2,6-Dichloroindophenol 3 beta-Hydroxy-delta-5-Steroid Dehydrogenase use Progesterone Reductase ... 2-Oxoisovalerate Dehydrogenase (Lipoamide) use 3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide) 2-PAM Compounds use ...
DeCS 2014 - December 16, 2014 version
2-Amino-5-phosphonovaleric Acid use 2-Amino-5-phosphonovalerate 2-Amino-6-(1,2,3-trihydroxypropyl)-4(3H)-pteridinone use ... 2-Dehydro-3-Deoxyphosphoheptonate Aldolase use 3-Deoxy-7-Phosphoheptulonate Synthase 2-Fluoro-2-deoxy-D-glucose use ... 2,6-Dichlorophenolindophenol use 2,6-Dichloroindophenol 3 beta-Hydroxy-delta-5-Steroid Dehydrogenase use Progesterone Reductase ... 2-Oxoisovalerate Dehydrogenase (Lipoamide) use 3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide) 2-PAM Compounds use ...
DeCS 2011 - December 22, 2011 version
2-Amino-5-phosphonovaleric Acid use 2-Amino-5-phosphonovalerate 2-Amino-6-(1,2,3-trihydroxypropyl)-4(3H)-pteridinone use ... 2-Dehydro-3-Deoxyphosphoheptonate Aldolase use 3-Deoxy-7-Phosphoheptulonate Synthase 2-Fluoro-2-deoxy-D-glucose use ... 2,6-Dichlorophenolindophenol use 2,6-Dichloroindophenol 3 beta-Hydroxy-delta-5-Steroid Dehydrogenase use Progesterone Reductase ... 2-Oxoisovalerate Dehydrogenase (Lipoamide) use 3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide) 2-PAM Compounds use ...
DeCS 2016 - July 28, 2016 version
2-Amino-5-phosphonovaleric Acid use 2-Amino-5-phosphonovalerate 2-Amino-6-(1,2,3-trihydroxypropyl)-4(3H)-pteridinone use ... 2-Dehydro-3-Deoxyphosphoheptonate Aldolase use 3-Deoxy-7-Phosphoheptulonate Synthase 2-Fluoro-2-deoxy-D-glucose use ... 2,6-Dichlorophenolindophenol use 2,6-Dichloroindophenol 3 beta-Hydroxy-delta-5-Steroid Dehydrogenase use Progesterone Reductase ... 2-Oxoisovalerate Dehydrogenase (Lipoamide) use 3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide) 2-PAM Compounds use ...
DeCS 2009 - February 20, 2009 version
2-Fluoro-2-deoxyglucose use Fluorodeoxyglucose F18 2H-Benzo(a)quinolizin-2-ol, 2-Ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10- ... 2-Amino-5-phosphonovaleric Acid use 2-Amino-5-phosphonovalerate 2-Amino-6-(1,2,3-trihydroxypropyl)-4(3H)-pteridinone use ... 2-Oxoisovalerate Dehydrogenase (Lipoamide) use 3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide) 2-PAM Compounds use ... 2-Chloroethyl Alcohol use Ethylene Chlorohydrin 2-Dehydro-3-Deoxyphosphoheptonate Aldolase use 3-Deoxy-7-Phosphoheptulonate ...
DeCS 2010 - February 12, 2010 version
2-Amino-5-phosphonovaleric Acid use 2-Amino-5-phosphonovalerate 2-Amino-6-(1,2,3-trihydroxypropyl)-4(3H)-pteridinone use ... 2-Dehydro-3-Deoxyphosphoheptonate Aldolase use 3-Deoxy-7-Phosphoheptulonate Synthase 2-Fluoro-2-deoxy-D-Glucose use ... 2,6-Dichlorophenolindophenol use 2,6-Dichloroindophenol 3 beta-Hydroxy-delta-5-Steroid Dehydrogenase use Progesterone Reductase ... 2-Oxoisovalerate Dehydrogenase (Lipoamide) use 3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide) 2-PAM Compounds use ...
DeCS 2009 - February 20, 2009 version
2-Fluoro-2-deoxyglucose use Fluorodeoxyglucose F18 2H-Benzo(a)quinolizin-2-ol, 2-Ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10- ... 2-Amino-5-phosphonovaleric Acid use 2-Amino-5-phosphonovalerate 2-Amino-6-(1,2,3-trihydroxypropyl)-4(3H)-pteridinone use ... 2-Oxoisovalerate Dehydrogenase (Lipoamide) use 3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide) 2-PAM Compounds use ... 2-Chloroethyl Alcohol use Ethylene Chlorohydrin 2-Dehydro-3-Deoxyphosphoheptonate Aldolase use 3-Deoxy-7-Phosphoheptulonate ...
DeCS 2012 - February 22, 2012 version
2-Amino-5-phosphonovaleric Acid use 2-Amino-5-phosphonovalerate 2-Amino-6-(1,2,3-trihydroxypropyl)-4(3H)-pteridinone use ... 2-Dehydro-3-Deoxyphosphoheptonate Aldolase use 3-Deoxy-7-Phosphoheptulonate Synthase 2-Fluoro-2-deoxy-D-glucose use ... 2,6-Dichlorophenolindophenol use 2,6-Dichloroindophenol 3 beta-Hydroxy-delta-5-Steroid Dehydrogenase use Progesterone Reductase ... 2-Oxoisovalerate Dehydrogenase (Lipoamide) use 3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide) 2-PAM Compounds use ...
DeCS 2013 - July 15, 2013 version
2-Amino-5-phosphonovaleric Acid use 2-Amino-5-phosphonovalerate 2-Amino-6-(1,2,3-trihydroxypropyl)-4(3H)-pteridinone use ... 2-Dehydro-3-Deoxyphosphoheptonate Aldolase use 3-Deoxy-7-Phosphoheptulonate Synthase 2-Fluoro-2-deoxy-D-glucose use ... 2,6-Dichlorophenolindophenol use 2,6-Dichloroindophenol 3 beta-Hydroxy-delta-5-Steroid Dehydrogenase use Progesterone Reductase ... 2-Oxoisovalerate Dehydrogenase (Lipoamide) use 3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide) 2-PAM Compounds use ...
DeCS 2013 - December 17, 2013 version
2-Amino-5-phosphonovaleric Acid use 2-Amino-5-phosphonovalerate 2-Amino-6-(1,2,3-trihydroxypropyl)-4(3H)-pteridinone use ... 2-Dehydro-3-Deoxyphosphoheptonate Aldolase use 3-Deoxy-7-Phosphoheptulonate Synthase 2-Fluoro-2-deoxy-D-glucose use ... 2,6-Dichlorophenolindophenol use 2,6-Dichloroindophenol 3 beta-Hydroxy-delta-5-Steroid Dehydrogenase use Progesterone Reductase ... 2-Oxoisovalerate Dehydrogenase (Lipoamide) use 3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide) 2-PAM Compounds use ...
DeCS 2012 - February 22, 2012 version
2-Amino-5-phosphonovaleric Acid use 2-Amino-5-phosphonovalerate 2-Amino-6-(1,2,3-trihydroxypropyl)-4(3H)-pteridinone use ... 2-Dehydro-3-Deoxyphosphoheptonate Aldolase use 3-Deoxy-7-Phosphoheptulonate Synthase 2-Fluoro-2-deoxy-D-glucose use ... 2,6-Dichlorophenolindophenol use 2,6-Dichloroindophenol 3 beta-Hydroxy-delta-5-Steroid Dehydrogenase use Progesterone Reductase ... 2-Oxoisovalerate Dehydrogenase (Lipoamide) use 3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide) 2-PAM Compounds use ...
Browse Items · NEOMED Bibliography Database
Excitatory Amino Acid Agonists/pharmacology, Female, Hippocampus/*drug effects, Isoquinolines/pharmacology, Lee G Y, Long-Term ... Tags: *GABA-A Receptor Antagonists, 1992, 2-Amino-5-phosphonovalerate/pharmacology, Animals, Baclofen/pharmacology, Harrison N ... Tags: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine, 1996, Animals, Anticonvulsants/*pharmacology, Brain research bulletin, ...
DeCS 2008 - May 16, 2008 version
3-Keto-5-alpha-Steroid delta-4-Dehydrogenase use Testosterone 5-alpha-Reductase ... 2H-Benzo(a)quinolizin-2-ol, 2-Ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy- ... 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester ... 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer ...
Search Results | Biochemical Society Transactions | Portland Press
Sulphur-containing excitatory amino acids in intercellular communication M. Cuénod, P. Grandes, L. Zängerle, P. Streit, K. Q. ... potentiation NMDA, N -methyl-D-aspartate OG, n -octyl-β-glucopyranoside PKC, protein kinase C Excitatory Amino Acids 36. 37. 38 ... NMDA, N -methyl- d -aspartate KA, kainate AMPA, α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate LIVBP, leucine, isoleucine, ... DEBORAH M. REECE; PETER B. NUNN 20 6 1988 © 1989 Biochemical Society 1989 BMAA, l-α-amino-β-methylaminopropionic acid NMDA, N - ...
Neuronal plasticity. Medical search. Website summaries
DevelopmentalSynaptic PotentialsCell SurvivalCell CountReaction TimeAmino Acid SequenceEvoked PotentialsEnvironmentEvoked ... AMPANeuropeptidesCyclic AMP Response Element-Binding ProteinNerve Growth FactorsExcitatory Amino Acid AntagonistsCalcium- ... S1), repeated pairing of a synaptic stimulation with a postsynaptic spike 5 ms later resulted in LTP of the synaptic response ( ... Oxide Synthase Type ICocaineEnzyme InhibitorsMembrane Proteinsgamma-Aminobutyric AcidNeuroprotective AgentsExcitatory Amino ...
Transition from reversible to persistent binding of CaMKII to postsynaptic sites and NR2B. | Cervo Brain Research Centre
Growth Factor Receptors - p38 MAP-Kinases pathway regulation, function and role p38 MAP-Kinases pathway
Supplementary antibodies had been conjugated to fluorescein, Tx Crimson, or 7-amino-4-methylcoumarin-3-acetic acidity (Vector ... 7-amino-actinomycin D (7-AAD) (Becton Dickinson, Franklin Lakes, NJ, USA) and Syto40 (Existence Systems from Thermo Fisher ... the civilizations had been treated chronically from 14C21 d in lifestyle with 100 m2-amino-5-phosphonovalerate (APV) as defined ... 2) and (3) could be combined to supply the idealized lumped parameter for H2O2 with this research. Presuming Elobixibat a ...
NMDA8
- Infusion of an NMDA receptor antagonist (AP-5, 1.97 micrograms/side), a kainate/alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonist (CNQX, 0.83 microgram/side), or both drugs together had no significant effects on conditioned reward or reinstatement of cocaine self-administration. (nih.gov)
- Consistent with a prior report indicating that N -methyl- d -aspartate (NMDA) receptor (NMDAR) activation can promote steroid production, we observed that d -2-amino-5-phosphonovalerate (APV), a competitive NMDAR antagonist, blocked the effects of 60 m m ethanol on staining. (jneurosci.org)
- For experiments (including electrophysiology) in which we examined the role of 5α-reductase in the effects of ethanol or NMDA, inhibitors of the enzyme were administered for at least 15 min before the other agents. (jneurosci.org)
- This residual current was due to non-NMDA receptor activation since application of 25 microM 2-amino-5-phosphonovalerate (APV) together with CGP 37849 did not significantly alter the residual current, whereas application of 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) with CGP 37849 did significantly inhibit this current. (unboundmedicine.com)
- Thus, the potent NMDA antagonists CGP 37849 and CGP 39551 were shown to inhibit excitatory amino acid responses specifically by competitive binding to the neurotransmitter recognition site of the NMDA receptor. (unboundmedicine.com)
- La forma L es inactiva en los receptores de NMDA pero puede afectar a los receptores de aminoácidos excitatorios (2-amino-4-fosfonobutirato;APB). (bvsalud.org)
- For studies from the NMDA receptor, the civilizations had been treated chronically from 14C21 d in lifestyle with 100 m2-amino-5-phosphonovalerate (APV) as defined previously (Rao and Craig, 1997). (forgetmenotinitiative.org)
- Latrunculin A was isolated in the Red Ocean sponge (known previously asFor immunocytochemistry not really regarding NMDA receptors, neurons had been set at 20C23 d in lifestyle in P110δ-IN-1 (ME-401) warm 4% paraformaldehyde and 4% sucrose in PBS for 15 min and had been permeabilized with 0.25% Triton X-100 for 5 min. (forgetmenotinitiative.org)
Receptors1
- APB) excitatory amino acid receptors. (bvsalud.org)
Kainate1
- Current evoked by 5 microM kainate or 5 microM alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) was unaffected by 10 microM CGP 39551. (unboundmedicine.com)
Acids1
- The effects of CGP 37849 [DL-(E)-2-amino-4-methyl-5-phosphono-3-pentenoate] and its ethylester CGP 39551 on whole-cell currents evoked by the endogenous excitatory amino acids, L-glutamate and L-aspartate, were studied in cultured mouse spinal cord neurones. (unboundmedicine.com)
Antagonists2
- Although CGP 37849 was the more potent compound, both antagonists inhibited 20 microM L-aspartate or 2 microM L-glutamate currents concentration-dependently and reversibly. (unboundmedicine.com)
- Upon application of 1 microM CGP 37849 and 10 microM CGP 39551, the L-aspartate concentration--current curve shifted to higher concentrations, and resulted in a 5- and 13-fold increase in the EC50 of L-aspartate, respectively, whereas Imax was not changed by application of the antagonists. (unboundmedicine.com)
Receptor1
- In contrast, infusion of a DA D1 receptor antagonist (SCH-23390, 2 micrograms/side) or a combination of SCH-23390 and a DA D2/D3 receptor antagonist (raclopride, 5 micrograms/side) significantly reduced responding for conditioned reward, but did not affect cocaine self-administration. (nih.gov)
Neurons2
- Using an antibody against 5α-reduced neurosteroids, predominantly allopregnanolone, we found that immunostaining in the CA1 region of rat hippocampal slices was confined to pyramidal neurons. (jneurosci.org)
- Neurons had been incubated in principal antibodies for 2 hr at 37C and in suitable supplementary antibodies for 45 min at 37C. (forgetmenotinitiative.org)
Reward1
- This so-called reward over-representation is similar to the CA1 activity adaptations previously found to be required for the successful learning of the reward location 5 . (nature.com)
20181
- 2018. 68(2): 216-226. (sciencejournals.ru)
Type1
- To observe the clinical curative effects of alprostadil combined with calcium dobesilate in type 2 diabetes patients w. (nel.edu)
Activity1
- With a spiking neuron model and linear prediction, evidence is adduced that the neuron learns two components: (1) the level of average background activity and (2) specific spike times of a pattern. (lookformedical.com)